These results indicate that selective blockade of TLR2 activity, but not TLR4, could inhibit Dox-induced cardiac dysfunction, suggesting that TLR2 and TLR4 may be involved in the progression of Dox-induced cardiomyopathy by different mechanisms. Here, TLR2 is linked to cardiomyopathy.